A RAND/UCLA-Modified VAS Study on Telemedicine, Telehealth, and Virtual Care in Daily Clinical Practice of Vascular Medicine
Background: Telemedicine is increasingly used in several fields of healthcare, including vascular medicine. This study aimed to investigate the views of experts and propose clinical practice recommendations on the possible applications of telemedicine in vascular medicine. Methods: A clinical guidance group proposed a set of 67 clinical practice recommendations based on the synthesis of current evidence and expert opinion. The Telemedicine Vascular Medicine Working Group included 32 experts from Europe evaluating the appropriateness of each clinical practice recommendation based on published RAND/UCLA methodology in two rounds. Results: In the first round, 60.9% of clinical practice recommendations were rated as appropriate, 35.9% as uncertain, and 3.1% as inappropriate. The strongest agreement (a median value of 10) was reached on statements regarding the usefulness of telemedicine during the 2019 coronavirus disease (COVID-19) pandemic, its usefulness for geographical areas that are difficult to access, and the superiority of video calls compared to phone calls only. The lowest degree of agreement (a median value of 2) was reported on statements regarding the utility of telemedicine being limited to the COVID-19 pandemic and regarding the applicability of teleconsultation in the diagnosis and management of abdominal aortic aneurysm. In the second round, 11 statements were re-evaluated to reduce variability. Conclusions: This study highlights the levels of agreement and the points that raise concern on the use of telemedicine in vascular medicine. It emphasizes the need for further clarification on various issues, including infrastructure, logistics, and legislation.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Journal of clinical medicine - 13(2024), 6 vom: 18. März |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 30.03.2024 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/jcm13061750 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370315189 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370315189 | ||
| 003 | DE-627 | ||
| 005 | 20240331001805.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240329s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/jcm13061750 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1357.xml |
| 035 | |a (DE-627)NLM370315189 | ||
| 035 | |a (NLM)38541976 | ||
| 035 | |a (PII)1750 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Pillon, Sergio |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A RAND/UCLA-Modified VAS Study on Telemedicine, Telehealth, and Virtual Care in Daily Clinical Practice of Vascular Medicine |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 30.03.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Background: Telemedicine is increasingly used in several fields of healthcare, including vascular medicine. This study aimed to investigate the views of experts and propose clinical practice recommendations on the possible applications of telemedicine in vascular medicine. Methods: A clinical guidance group proposed a set of 67 clinical practice recommendations based on the synthesis of current evidence and expert opinion. The Telemedicine Vascular Medicine Working Group included 32 experts from Europe evaluating the appropriateness of each clinical practice recommendation based on published RAND/UCLA methodology in two rounds. Results: In the first round, 60.9% of clinical practice recommendations were rated as appropriate, 35.9% as uncertain, and 3.1% as inappropriate. The strongest agreement (a median value of 10) was reached on statements regarding the usefulness of telemedicine during the 2019 coronavirus disease (COVID-19) pandemic, its usefulness for geographical areas that are difficult to access, and the superiority of video calls compared to phone calls only. The lowest degree of agreement (a median value of 2) was reported on statements regarding the utility of telemedicine being limited to the COVID-19 pandemic and regarding the applicability of teleconsultation in the diagnosis and management of abdominal aortic aneurysm. In the second round, 11 statements were re-evaluated to reduce variability. Conclusions: This study highlights the levels of agreement and the points that raise concern on the use of telemedicine in vascular medicine. It emphasizes the need for further clarification on various issues, including infrastructure, logistics, and legislation | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a telehealth | |
| 650 | 4 | |a telemedicine | |
| 650 | 4 | |a vascular medicine | |
| 700 | 1 | |a Gomatou, Georgia |e verfasserin |4 aut | |
| 700 | 1 | |a Dimakakos, Evangelos |e verfasserin |4 aut | |
| 700 | 1 | |a Stanek, Agata |e verfasserin |4 aut | |
| 700 | 1 | |a Pecsvarady, Zsolt |e verfasserin |4 aut | |
| 700 | 1 | |a Kozak, Matija |e verfasserin |4 aut | |
| 700 | 1 | |a Wautrecht, Jean-Claude |e verfasserin |4 aut | |
| 700 | 1 | |a Farkas, Katalin |e verfasserin |4 aut | |
| 700 | 1 | |a Schernthaner, Gerit-Holger |e verfasserin |4 aut | |
| 700 | 1 | |a Catalano, Mariella |e verfasserin |4 aut | |
| 700 | 1 | |a Blinc, Aleš |e verfasserin |4 aut | |
| 700 | 1 | |a Gerotziafas, Grigorios |e verfasserin |4 aut | |
| 700 | 1 | |a Poredoš, Pavel |e verfasserin |4 aut | |
| 700 | 1 | |a De Marchi, Sergio |e verfasserin |4 aut | |
| 700 | 1 | |a Gschwandtner, Michael E |e verfasserin |4 aut | |
| 700 | 1 | |a Kolossváry, Endre |e verfasserin |4 aut | |
| 700 | 1 | |a Sprynger, Muriel |e verfasserin |4 aut | |
| 700 | 1 | |a Fazeli, Bahar |e verfasserin |4 aut | |
| 700 | 1 | |a Liew, Aaron |e verfasserin |4 aut | |
| 700 | 1 | |a Marschang, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Szuba, Andrzej |e verfasserin |4 aut | |
| 700 | 1 | |a Suput, Dusan |e verfasserin |4 aut | |
| 700 | 1 | |a Edmonds, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Manu, Chris |e verfasserin |4 aut | |
| 700 | 1 | |a Schaefer, Christian Alexander |e verfasserin |4 aut | |
| 700 | 1 | |a Marakomichelakis, George |e verfasserin |4 aut | |
| 700 | 1 | |a Vrkić Kirhmajer, Majda |e verfasserin |4 aut | |
| 700 | 1 | |a Spaak, Jonas |e verfasserin |4 aut | |
| 700 | 1 | |a Kotteas, Elias |e verfasserin |4 aut | |
| 700 | 1 | |a Lessiani, Gianfranco |e verfasserin |4 aut | |
| 700 | 1 | |a Colgan, Mary Paola |e verfasserin |4 aut | |
| 700 | 1 | |a Righini, Marc |e verfasserin |4 aut | |
| 700 | 1 | |a Lichtenberg, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Schlager, Oliver |e verfasserin |4 aut | |
| 700 | 1 | |a Canning, Caitriona |e verfasserin |4 aut | |
| 700 | 1 | |a Marcoccia, Antonella |e verfasserin |4 aut | |
| 700 | 1 | |a Kollias, Anastasios |e verfasserin |4 aut | |
| 700 | 1 | |a Spreafico, Alberta |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical medicine |d 2012 |g 13(2024), 6 vom: 18. März |w (DE-627)NLM230666310 |x 2077-0383 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2024 |g number:6 |g day:18 |g month:03 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/jcm13061750 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2024 |e 6 |b 18 |c 03 | ||